ConductScience.org, home

Paper33803151

The Role of microRNAs in the Cisplatin- and Radio-Resistance of Cervical Cancer.

Masadah R and 4 others. Cancers (Basel), 2021. Cited by 35 papers, by iCite.

Cite this record

ConductScience Library. The Role of microRNAs in the Cisplatin- and Radio-Resistance of Cervical Cancer. Papers, record 33803151. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/33803151

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
The Role of microRNAs in the Cisplatin- and Radio-Resistance of Cervical Cancer.
PubMed
Journal
Cancers (Basel)
PubMed
Year
2021
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
35
iCite
Relative citation ratio, by iCite
2.25
iCite
Revised in PubMed
2021-04-08
PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Masadah RRina
2Rauf SSyahrul
3Pratama MYMuhammad Yogi
4Tiribelli CClaudiohttps://orcid.org/0000-0001-6596-7595
5Pascut DDevishttps://orcid.org/0000-0003-0583-1973

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

Grants2

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
NAIndonesia Endowment Fund for Education (LPDP)PubMed
NAFondazione Italiana Fegato-ONLUSPubMed

Source PubMed

Download CSV of grants

References98

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
118767981PTEN and the PI3-kinase pathway in cancer.Annu Rev Pathol2009https://conductscience.org/library/papers/18767981PubMed
219694703Osteopontin expression correlates with invasiveness in cervical cancer.Aust N Z J Obstet Gynaecol2009https://conductscience.org/library/papers/19694703PubMed
327354763Molecular mechanisms of cisplatin resistance in cervical cancer.Drug Des Devel Ther2016https://conductscience.org/library/papers/27354763PubMed
425324171Oncogenicity of LHX2 in pancreatic ductal adenocarcinoma.Mol Biol Rep2014https://conductscience.org/library/papers/25324171PubMed
526878391MiR-125a promotes paclitaxel sensitivity in cervical cancer through altering STAT3 expression.Oncogenesis2016https://conductscience.org/library/papers/26878391PubMed
627904781MicroRNA-497 regulates cisplatin chemosensitivity of cervical cancer by targeting transketolase.Am J Cancer Res2016https://conductscience.org/library/papers/27904781PubMed
78463044Natural history of cervical intraepithelial neoplasia: a critical review.Int J Gynecol Pathol1993https://conductscience.org/library/papers/8463044PubMed
827040383Nuclear factor-κB-dependent microRNA-130a upregulation promotes cervical cancer cell growth by targeting phosphatase and tensin homolog.Arch Biochem Biophys2016https://conductscience.org/library/papers/27040383PubMed
919853287Prognostic factors for response to cisplatin-based chemotherapy in advanced cervical carcinoma: a Gynecologic Oncology Group Study.Gynecol Oncol2010https://conductscience.org/library/papers/19853287PubMed
1030219819MicroRNA-7-5p Promotes Cisplatin Resistance of Cervical Cancer Cells and Modulation of Cellular Energy Homeostasis by Regulating the Expression of the PARP-1 and BCL2 Genes.Med Sci Monit2018https://conductscience.org/library/papers/30219819PubMed
1110202165Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer.N Engl J Med1999https://conductscience.org/library/papers/10202165PubMed
1229872582High mobility group box 1 (HMGB1) acts as an "alarmin" to promote acute myeloid leukaemia progression.Oncoimmunology2018https://conductscience.org/library/papers/29872582PubMed
1325037503The pentose phosphate pathway and cancer.Trends Biochem Sci2014https://conductscience.org/library/papers/25037503PubMed
1420065848Comparison between conventional surgery plus postoperative adjuvant radiotherapy and concurrent chemoradiation for FIGO stage IIB cervical carcinoma: a retrospective study.Am J Clin Oncol2010https://conductscience.org/library/papers/20065848PubMed
1524077440The role of oxidative stress in the development of cisplatin resistance in epithelial ovarian cancer.Reprod Sci2014https://conductscience.org/library/papers/24077440PubMed
1622287315Glucocorticoid regulation of a novel HPV-E6-p53-miR-145 pathway modulates invasion and therapy resistance of cervical cancer cells.J Pathol2012https://conductscience.org/library/papers/22287315PubMed
173894589Randomized trial of three cisplatin dose schedules in squamous-cell carcinoma of the cervix: a Gynecologic Oncology Group study.J Clin Oncol1985https://conductscience.org/library/papers/3894589PubMed
1832244055Semaphorin 4A, 4C, and 4D: Function comparison in the autoimmunity, allergy, and cancer.Gene2020https://conductscience.org/library/papers/32244055PubMed
1931190335miR-4429 sensitized cervical cancer cells to irradiation by targeting RAD51.J Cell Physiol2020https://conductscience.org/library/papers/31190335PubMed
2029099271SOX9/miR-130a/CTR1 axis modulates DDP-resistance of cervical cancer cell.Cell Cycle2018https://conductscience.org/library/papers/29099271PubMed

See all 98 referencesDownload CSV of references

Cited by28

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 35 citations.

PMIDTitleJournalYearIn PapersSource
42903611Chemoresistance in cervical cancer: identifying and exploiting non-coding RNAs.Front Oncol2026https://conductscience.org/library/papers/42903611PubMed
42668735A comprehensive review on apoptotic miRNAs and antagomiRs in breast cancer: Enhancing radio sensitization.Genes Dis2026https://conductscience.org/library/papers/42668735PubMed
42363253Decoding the association between platinum resistance and HPV status in cervical cancer using organoid models.BMC Biol2026https://conductscience.org/library/papers/42363253PubMed
41113473LncRNA-EME1 enhances BRCA1 recruitment and alters repair of DNA damage in cervical cancer radioresistance.Noncoding RNA Res2026https://conductscience.org/library/papers/41113473PubMed
40641137MicroRNAs: Novel clinical biomarkers for cancer radiotherapy (Review).Mol Med Rep2025https://conductscience.org/library/papers/40641137PubMed
40534305Hsa_circ_0101308 adjusted by N6-methyladenosine (m6A) impacts chemo-resistance in cervical cancer via sponging miR-224.Cancer Biomark2025https://conductscience.org/library/papers/40534305PubMed
40358898Interplay between NETosis and the lncRNA-microRNA regulatory axis in the immunopathogenesis of cancer.J Physiol Biochem2025https://conductscience.org/library/papers/40358898PubMed
40076427Development and Characterization of Three Novel FGFR Inhibitor Resistant Cervical Cancer Cell Lines to Help Drive Cervical Cancer Research.Int J Mol Sci2025https://conductscience.org/library/papers/40076427PubMed
39346724Cleft lip and palate transmembrane protein 1-like is a putative regulator of tumorigenesis and sensitization of cervical cancer cells to cisplatin.Front Oncol2024https://conductscience.org/library/papers/39346724PubMed
39263322Understanding the role of miRNAs in cervical cancer pathogenesis and therapeutic responses.Front Cell Dev Biol2024https://conductscience.org/library/papers/39263322PubMed
39147708[Research Progress of Engineered Exosomes in the Treatment of Lung Cancer].Zhongguo Fei Ai Za Zhi2024https://conductscience.org/library/papers/39147708PubMed
38327905Exploring a novel seven-gene marker and mitochondrial gene TMEM38A for predicting cervical cancer radiotherapy sensitivity using machine learning algorithms.Front Endocrinol (Lausanne)2023https://conductscience.org/library/papers/38327905PubMed
38067329The Role of ZNF275/AKT Pathway in Carcinogenesis and Cisplatin Chemosensitivity of Cervical Cancer Using Patient-Derived Xenograft Models.Cancers (Basel)2023https://conductscience.org/library/papers/38067329PubMed
37804407Evaluation of Long Non-coding RNA (LncRNA) in the Pathogenesis of Chemotherapy Resistance in Cervical Cancer: Diagnostic and Prognostic Approach.Mol Biotechnol2024https://conductscience.org/library/papers/37804407PubMed
37593506Two Enhances the Cisplatin Sensitivity of Cervical Cancer Cells via Suppression of c-MET Expression.Iran J Public Health2023https://conductscience.org/library/papers/37593506PubMed
37140697BRSK1 confers cisplatin resistance in cervical cancer cells via regulation of mitochondrial respiration.J Cancer Res Clin Oncol2023https://conductscience.org/library/papers/37140697PubMed
36922504Engineered exosomes from different sources for cancer-targeted therapy.Signal Transduct Target Ther2023https://conductscience.org/library/papers/36922504PubMed
36875073Emerging role of interaction between m6A and main ncRNAs in gastrointestinal (GI) cancers.Front Immunol2023https://conductscience.org/library/papers/36875073PubMed
36793374Effect of Exosomal lncRNA MALAT1/miR-370-3p/STAT3 Positive Feedback Loop on PI3K/Akt Pathway Mediating Cisplatin Resistance in Cervical Cancer Cells.J Oncol2023https://conductscience.org/library/papers/36793374PubMed
36632741Circular RNA ARHGAP5 inhibits cisplatin resistance in cervical squamous cell carcinoma by interacting with AUF1.Cancer Sci2023https://conductscience.org/library/papers/36632741PubMed

See all 28 cited byDownload CSV of cited by

Genes74

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
ABCB15243PubTator's text mininghttps://conductscience.org/library/genes/5243NCBI Gene
ABCG29429PubTator's text mininghttps://conductscience.org/library/genes/9429NCBI Gene
AKT1207PubTator's text mininghttps://conductscience.org/library/genes/207NCBI Gene
ALDH1A1216PubTator's text mininghttps://conductscience.org/library/genes/216NCBI Gene
BCL2596PubTator's text mininghttps://conductscience.org/library/genes/596NCBI Gene
BCL2L1598PubTator's text mininghttps://conductscience.org/library/genes/598NCBI Gene
BCL2L2599PubTator's text mininghttps://conductscience.org/library/genes/599NCBI Gene
BCRP1644079PubTator's text mininghttps://conductscience.org/library/genes/644079NCBI Gene
BECN18678PubTator's text mininghttps://conductscience.org/library/genes/8678NCBI Gene
BMI1648PubTator's text mininghttps://conductscience.org/library/genes/648NCBI Gene
BTG310950PubTator's text mininghttps://conductscience.org/library/genes/10950NCBI Gene
CASC2255082PubTator's text mininghttps://conductscience.org/library/genes/255082NCBI Gene
CASP8841PubTator's text mininghttps://conductscience.org/library/genes/841NCBI Gene
CASP9842PubTator's text mininghttps://conductscience.org/library/genes/842NCBI Gene
CD44960PubTator's text mininghttps://conductscience.org/library/genes/960NCBI Gene
CDH1999PubTator's text mininghttps://conductscience.org/library/genes/999NCBI Gene
EIF4E1977PubTator's text mininghttps://conductscience.org/library/genes/1977NCBI Gene
FBXL526234PubTator's text mininghttps://conductscience.org/library/genes/26234NCBI Gene
G6PD2539PubTator's text mininghttps://conductscience.org/library/genes/2539NCBI Gene
GAS560674PubTator's text mininghttps://conductscience.org/library/genes/60674NCBI Gene

See all 74 genesDownload CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/33803151

GET https://conductscience.org/api/papers/v1/33803151/references?page=2